PARG and breast neoplasm: Using a Brca2 mouse model of breast tumors, Gogola and colleagues showed that inactivation of poly(ADP-ribose) glycohydrolase (PARG), which catalyzes PARP poly(ADP–ribose) degradation, is another mechanism of acquired resistance to PARP inhibition [181,182].